The White House today unveiled plans to vaccinate 28 million 5- to 11-year olds for COVID, and the Centers for Disease Control and Prevention has already issued guidance for the vaccines for that age group, even though the U.S. Food and Drug Administration has yet to approve Pfizer’s vaccine for young children.
The White House today unveiled plans to roll out COVID vaccines for children ages 5 to 11, even though vaccine safety experts — who advise U.S. drug regulators and review safety and efficacy data — have not met to discuss whether Pfizer’s COVID vaccine should be authorized for use in the pediatric age group.
“By the White House already purchasing 65 million pediatric doses of the Pfizer-BioNTech vaccine, and the CDC putting out guidelines ahead of FDA authorization — let alone, a recommendation by its own Advisory Committee on Immunization and Practices — these actors are revealing the whole vaccine regulatory process to be a complete sham,” said Mary Holland, president of Children’s Health Defense in an email to The Defender.
“There could be no better way to undermine public confidence than to make it clear that this is politics, not science.”‘This Is Politics, Not Science’: White House, CDC Prepare to Vaccinate 5- to 11-Year-Olds Prior to FDA Authorization • Children’s Health Defense
Whatever happened to the precautionary principle?